NEWS

Mar 28,2022

Epidemic prevention and control, we are in action

After the emergence of the "3.13" epidemic in Jinhua Jindong District, in order to do a good job in the prevention and control of the new coronary pneumonia epidemic, to ensure the health and safety of employees, Jianfeng Group and the subordinate enterprises in Jin actively deployed, the implementation of the prevention and control work.

Key words:

Epidemic prevention and control, we are in action

Mar 28,2022

Peak Pharmaceutical Production Department Launches Theme Party Class

On March 18, the party branch of the production department of peak pharmaceutical organized party members to carry out thematic party classes, publicize and implement SASAC documents, and learn the basic knowledge of the party.

Key words:

Peak Pharmaceutical Production Department Launches Theme Party Class

Mar 28,2022

The pharmaceutical production department organizes female workers for an outing.

On March 12, Jianfeng Pharmaceutical Production Department organized all female workers to visit Jedao Mountain Scenic Area in Lingxia Town, jindong district.

Key words:

The pharmaceutical production department organizes female workers for an outing.

Apr 11,2022

Opinions of the General Department of the State Food and Drug Administration on Strengthening the Collaborative Supervision of Cross-regional Commissioned Production of Medical Devices

The implementation of the medical device registrant system is an important measure to promote the reform of the medical device review and approval system and strengthen the management of the whole life cycle of medical devices. With the implementation of the regulations on the Supervision and Administration of Medical Devices (decree No. 739 of the State Council), the registrant system has been fully implemented, and the organizational forms of medical device production have become more diverse. in particular, medical device registrants carry out entrusted production across provinces, autonomous regions and municipalities directly under the Central Government (hereinafter referred to as "cross-regional entrusted production"), involving the division of responsibilities and coordination of provincial drug regulatory departments, bringing new challenges to the regulatory work. In order to effectively strengthen the supervision of cross-regional entrusted production by medical device registrants, consolidate the note.

Key words:

Opinions of the General Department of the State Food and Drug Administration on Strengthening the Collaborative Supervision of Cross-regional Commissioned Production of Medical Devices

Apr 11,2022

Summary: Best time to take cardiovascular drugs

‍‍There are many kinds of cardiovascular diseases, and the corresponding treatment drugs are also numerous. When patients are faced with many drugs, it is easy to be puzzled by a question: when should this drug be taken? Today, we hereby summarize the best medication time for some cardiovascular drugs, hoping to be helpful to everyone.

Key words:

Summary: Best time to take cardiovascular drugs

Apr 11,2022

The General Department of the State Food and Drug Administration publicly solicits opinions on the "Pharmaceutical Business Quality Management Practice-Drug Retail Distribution Quality Management Appendix (Draft for Solicitation of Comments)"

In order to further standardize the behavior of drug retail distribution and ensure the quality and safety of drugs in retail distribution, the State Food and Drug Administration has organized the drafting of the "Pharmaceutical Business quality Management Standard-Drug Retail Distribution quality Management Appendix (draft for soliciting opinions)" (Annex 1). Please fill in the feedback form (Annex 2) and send it back to the e-mail box before March 31, 2022: ypjgs@nmpa.gov.cn. Please indicate "Feedback on Appendix to Drug Retail Distribution Quality Management" in the subject of the e-mail ".

Key words:

The General Department of the State Food and Drug Administration publicly solicits opinions on the "Pharmaceutical Business Quality Management Practice-Drug Retail Distribution Quality Management Appendix (Draft for Solicitation of Comments)"
< 1...131132133...146 >
Chenglian Medicine

Follow us

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息： JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page